RMIT University
Browse

Synbiotics as Supplemental Therapy for the Alleviation of Chemotherapy-Associated Symptoms in Patients with Solid Tumours

journal contribution
posted on 2024-11-02, 23:16 authored by Neeraj Singh, Jeffrey Beckett, Krishnakumar Kalpurath, Muhammad Ishaq, Tauseef Ahmad, Rajaraman EriRajaraman Eri
Chemotherapy is still the first line of treatment for most cancer patients. Patients receiving chemotherapy are generally prone to infections, which result in complications, such as sepsis, mucositis, colitis, and diarrhoea. Several nutritional approaches have been trialled to counter the chemotherapy-associated side effects in cancer patients, but none have yet been approved for routine clinical use. One of the approaches to reduce or avoid chemotherapy-associated complications is to restore the gut microbiota. Gut microbiota is essential for the healthy functioning of the immune system, metabolism, and the regulation of other molecular responses in the body. Chemotherapy erodes the mucosal layer of the gastrointestinal tract and results in the loss of gut microbiota. One of the ways to restore the gut microbiota is through the use of probiotics. Probiotics are the ‘good’ bacteria that may provide health benefits if consumed in appropriate amounts. Some studies have highlighted that the consumption of probiotics in combination with prebiotics, known as synbiotics, may provide better health benefits when compared to probiotics alone. This review discusses the different nutritional approaches that have been studied in an attempt to combat chemotherapy-associated side effects in cancer patients with a particular focus on the use of pre-, pro- and synbiotics.

History

Related Materials

  1. 1.
    DOI - Is published in 10.3390/nu15071759
  2. 2.
    ISSN - Is published in 20726643

Journal

Nutrients

Volume

15

Number

1759

Issue

7

Start page

1

End page

17

Total pages

17

Publisher

MDPI

Place published

Basel, Switzerland

Language

English

Copyright

© 2023 Singh et al. Creative Commons Attribution (CC BY) license

Former Identifier

2006123258

Esploro creation date

2023-06-11

Usage metrics

    Scholarly Works

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC